Response to: 'Monocyte type I interferon signature in antiphospholipid syndrome is related to pro-inflammatory monocyte subsets, hydroxychloroquine and statin use' by van den Hoogen et al

Ann Rheum Dis. 2016 Dec;75(12):e82. doi: 10.1136/annrheumdis-2016-210529. Epub 2016 Oct 21.
No abstract available

Keywords: Antiphospholipid Syndrome; Disease Activity; Treatment.

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Antiphospholipid
  • Antiphospholipid Syndrome*
  • Humans
  • Hydroxychloroquine*
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Interferon Type I
  • Monocytes

Substances

  • Antibodies, Antiphospholipid
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Interferon Type I
  • Hydroxychloroquine